Plasma pharmacokinetics of once- versus twice-daily lamivudine and abacavir: simplification of combination treatment in HIV-1-infected children (PENTA-13). by Bergshoeff, A, Burger, D, Verweij, C, Farrelly, L, Flynn, J, Le Prevost, M, Walker, S, Novelli, V, Lyall, H, Khoo, S, Gibb, D

Adherence and acceptability of once daily Lamivudine and abacavir in human immunodeficiency virus type-1 infected children. by LePrevost, M, Green, H, Flynn, J, Head, S, Clapson, M, Lyall, H, Novelli, V, Farrelly, L, Walker, A, Burger, D, Gibb, D